Author | Erika P. Hamilton, MD | OncLive

Author | Erika P. Hamilton, MD

Articles

Dr. Hamilton on the Evolution of Treatment in HER2+ Breast Cancer

May 08, 2020

Video

Erika P. Hamilton, MD, discusses the evolution of treatment in HER2-positive breast cancer.

Dr. Hamilton on the FDA Approval of Tucatinib in HER2+ Breast Cancer

April 17, 2020

Video

Erika P. Hamilton, MD, director of the Breast Cancer and Gynecologic Research Program and principal investigator at Sarah Cannon Research Institute, discusses the FDA approval of tucatinib (Tukysa) in HER2-positive breast cancer.

Dr. Hamilton on Using pCR to Classify Risk in HER2+ Breast Cancer

April 09, 2020

Video

Erika P. Hamilton, MD, director of the Breast Cancer and Gynecologic Research Program and principal investigator at Sarah Cannon Research Institute, discusses the use of pathologic complete response (pCR) as a way to classify risk status in HER2-positive breast cancer.

Dr. Hamilton on the Results of the KATHERINE Trial in HER2+ Breast Cancer

February 14, 2020

Video

Erika P. Hamilton, MD, discusses the superiority of ado-trastuzumab emtansine (T-DM1; Kadcyla) in the phase III KATHERINE study.

x